SOFIE submits IND for [18F]-FAPI-74 in Phase 2 study of Gastrointestinal Cancers

Dulles, VA – October 31, 2022 – SOFIE Biosciences (SOFIE), an established US manufacturer and developer […]

2022-10-31T15:14:32+00:00October 31st, 2022|News|

First Patient Imaged in SOFIE’s FAPI Phase II Trial

SOFIE Biosciences (SOFIE), an established US manufacturer and developer of radiopharmaceuticals, has dosed and imaged […]

2022-10-13T01:06:32+00:00October 13th, 2022|News|

Monitoring Therapeutic Response to Anti-Fibroblast Activation Protein (FAP) CAR T Cells using [18F]AlF-FAPI-74

Iris K Lee, Estela Noguera-Ortega, Zebin Xiao, Leslie Todd, John Scholler, Decheng Song, Maria Liousia, […]

2022-09-30T16:03:08+00:00August 18th, 2022|Publications|

Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types

Ammar Alfteimi, Ulf Lützen, Alexander Helm, Michael Jüptner, Marlies Marx, Yi Zhao, Maaz Zuhayra

Abstract

2022-09-30T16:05:58+00:00July 29th, 2022|Publications|

Safety and efficacy of 90Y-FAPI-46 radioligand therapy in patients with advanced sarcoma and other cancer entities

Wolfgang P Fendler, Kim M Pabst, Lukas Kessler, Pedro Fragoso Costa, Justin Ferdinandus, Manuel Weber, […]

2023-01-16T23:05:48+00:00July 14th, 2022|Publications|

FAPI featured in accolades at annual Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting

Congratulations to investigators at Hannover School of Medicine and Heidelberg University Hospital for receiving the […]

2023-03-07T01:28:03+00:00June 30th, 2022|News|

FAP session at Society of Nuclear Medicine and Molecular Imaging (SNMMI) meeting attracts packed audience

SOFIE hosted a FAP session, together with Clovis […]

2022-06-24T17:36:30+00:00June 22nd, 2022|News|

Pitfalls and Common Findings in 68 Ga-FAPI PET: A Pictorial Analysis

Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, […]

2022-06-30T16:05:59+00:00June 1st, 2022|Publications|

SOFIE Opens 20,000 sq ft Theranostics Center of Excellence

Dulles, VA, April 27, 2022– SOFIE Co. (SOFIE), a Theranostics company, commissions its new […]

2022-05-26T15:35:06+00:00April 27th, 2022|News|

Comparison of 68 Ga-FAPI PET/CT and 18 FDG PET/CT Modalities in Gastrointestinal System Malignancies with Peritoneal Involvement

Umut Elboga, Ertan Sahin, Tulay Kus, Yusuf Burak Cayirli, Gokmen Aktas, Merve […]

2022-06-30T15:59:45+00:00April 11th, 2022|Publications|
Go to Top